Hartmut H. Malluche
#151,856
Most Influential Person Now
Hartmut H. Malluche's AcademicInfluence.com Rankings
Hartmut H. Malluchephilosophy Degrees
Philosophy
#8423
World Rank
#11806
Historical Rank
Logic
#5462
World Rank
#6866
Historical Rank
Hartmut H. Malluchebiology Degrees
Biology
#11407
World Rank
#14800
Historical Rank
Physiology
#363
World Rank
#580
Historical Rank
Download Badge
Philosophy Biology
Why Is Hartmut H. Malluche Influential?
(Suggest an Edit or Addition)Hartmut H. Malluche's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Bone histomorphometry: Standardization of nomenclature, symbols, and units: Report of the asbmr histomorphometry nomenclature committee (1987) (5046)
- K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease. (2003) (2521)
- Standardized nomenclature, symbols, and units for bone histomorphometry: A 2012 update of the report of the ASBMR Histomorphometry Nomenclature Committee (2013) (1974)
- Osteoblast-specific Knockout of the Insulin-like Growth Factor (IGF) Receptor Gene Reveals an Essential Role of IGF Signaling in Bone Matrix Mineralization* (2002) (679)
- Structural and cellular assessment of bone quality of proximal femur. (1993) (677)
- Renal bone disease 1990: an unmet challenge for the nephrologist. (1990) (355)
- Targeted overexpression of insulin-like growth factor I to osteoblasts of transgenic mice: increased trabecular bone volume without increased osteoblast proliferation. (2000) (353)
- Evidence for abnormal calcium homeostasis in patients with adynamic bone disease. (1994) (304)
- Bone histology in incipient and advanced renal failure. (1976) (298)
- Renal osteodystrophy in the first decade of the new millennium: Analysis of 630 bone biopsies in black and white patients (2011) (285)
- The Phytoestrogen Genistein Reduces Bone Loss in Short-Term Ovariectomized Rats (1998) (280)
- Predictive value of serum parathyroid hormone levels for bone turnover in patients on chronic maintenance dialysis. (1995) (255)
- Improved assessment of bone turnover by the PTH-(1-84)/large C-PTH fragments ratio in ESRD patients. (2001) (241)
- Prevention of bone loss in renal transplant recipients: a prospective, randomized trial of intravenous pamidronate. (2003) (240)
- Increased bone adiposity and peroxisomal proliferator-activated receptor-gamma2 expression in type I diabetic mice. (2005) (238)
- Sclerostin and Dickkopf-1 in renal osteodystrophy. (2011) (225)
- High prevalence of low bone turnover and occurrence of osteomalacia after kidney transplantation. (2000) (220)
- Diagnostic Accuracy of Bone Turnover Markers and Bone Histology in Patients With CKD Treated by Dialysis. (2016) (201)
- Early chronic kidney disease-mineral bone disorder stimulates vascular calcification (2013) (194)
- The use of deferoxamine in the management of aluminium accumulation in bone in patients with renal failure. (1984) (189)
- Atlas of Mineralized Bone Histology (1986) (174)
- Diagnosis, assessment, and treatment of bone turnover abnormalities in renal osteodystrophy. (2004) (173)
- Effects of sevelamer hydrochloride and calcium carbonate on renal osteodystrophy in hemodialysis patients. (2008) (165)
- Plasma levels of bone Gla-protein reflect bone formation in patients on chronic maintenance dialysis. (1984) (160)
- Evidence of functional vitamin D receptors in rat hippocampus (2001) (159)
- 1,25(OH)2D3 administration in moderate renal failure: a prospective double-blind trial. (1989) (155)
- Treatment with pyrophosphate inhibits uremic vascular calcification. (2011) (153)
- Aluminium and bone disease in chronic renal failure. (2002) (142)
- CKD-induced wingless/integration1 inhibitors and phosphorus cause the CKD-mineral and bone disorder. (2014) (142)
- Effect of bisphosphonates on vascular calcification and bone metabolism in experimental renal failure. (2009) (138)
- Food and Drug Administration Center for Drug Evaluation and Research (1996) (125)
- Differences in bone quality in low- and high-turnover renal osteodystrophy. (2012) (121)
- An assessment of cinacalcet HCl effects on bone histology in dialysis patients with secondary hyperparathyroidism. (2008) (114)
- Characterization of a response element in the 5'-flanking region of the avian (chicken) PTH gene that mediates negative regulation of gene transcription by 1,25-dihydroxyvitamin D3 and binds the vitamin D3 receptor. (1996) (113)
- Bone mineral density and serum biochemical predictors of bone loss in patients with CKD on dialysis. (2014) (111)
- INFANT FORMULA AS A CAUSE OF ALUMINIUM TOXICITY IN NEONATAL URAEMIA (1985) (111)
- Low bone volume--a risk factor for coronary calcifications in hemodialysis patients. (2009) (104)
- Intermittent and Continuous Administration of the Bisphosphonate Ibandronate in Ovariohysterectomized Beagle Dogs: Effects on Bone Morphometry and Mineral Properties (1999) (101)
- Skeletal abnormalities in chronic renal insufficiency before and during maintenance hemodialysis. (1973) (97)
- Biochemical Evidence of Metabolic Bone Disease in Women Following Roux-Y Gastric Bypass for Morbid Obesity (1992) (96)
- Administration of PTH-(7-84) antagonizes the effects of PTH-(1-84) on bone in rats with moderate renal failure. (2003) (96)
- Osteoblastic insufficiency is responsible for maintenance of osteopenia after loss of ovarian function in experimental beagle dogs. (1986) (94)
- Abnormal bone histology in idiopathic hypercalciuria. (1980) (94)
- The importance of bone health in end-stage renal disease: out of the frying pan, into the fire? (2004) (92)
- Improvements in renal osteodystrophy in patients treated with lanthanum carbonate for two years. (2008) (91)
- Paracrine Overexpression of IGFBP‐4 in Osteoblasts of Transgenic Mice Decreases Bone Turnover and Causes Global Growth Retardation (2003) (89)
- Bone Markers Predict Cardiovascular Events in Chronic Kidney Disease (2008) (85)
- Bone changes occurring early after cessation of ovarian function in beagle dogs: A histomorphometric study employing sequential biopsies (1990) (82)
- Stainable aluminum and not aluminum content reflects bone histology in dialyzed patients. (1986) (80)
- Calcific uremic arteriolopathy in association with low turnover uremic bone disease. (1999) (80)
- Aluminum-related bone disease in mild and advanced renal failure: evidence for high prevalence and morbidity and studies on etiology and diagnosis. (1986) (79)
- Animal models for the study of bone loss after cessation of ovarian function. (1993) (77)
- Iga nephropathy: presentation, clinical course, and prognosis in children and adults. (1984) (72)
- Evaluating bone quality in patients with chronic kidney disease (2013) (71)
- Calcitriol corrects bone loss induced by oophorectomy in rats. (1986) (69)
- Update on vitamin D and its newer analogues: actions and rationale for treatment in chronic renal failure. (2002) (67)
- Calcitonin Alters Bone Quality in Beagle Dogs (1997) (67)
- High Parathyroid Hormone Level and Osteoporosis Predict Progression of Coronary Artery Calcification in Patients on Dialysis. (2015) (67)
- Renal osteodystrophy: what's in a name? Presentation of a clinically useful new model to interpret bone histologic findings. (2006) (66)
- Bone resorption and mRNA expression of IL-6 and IL-6 receptor in patients with renal osteodystrophy. (1996) (66)
- Differences in bone turnover and intact PTH levels between African American and Caucasian patients with end-stage renal disease. (2003) (65)
- Parathyroid Hormone/Parathyroid Hormone‐Related Peptide Type 1 Receptor in Human Bone (2001) (63)
- Quantitative bone histology in 84 normal American subjects (1982) (62)
- Reduction of Dialysate Calcium Level Reduces Progression of Coronary Artery Calcification and Improves Low Bone Turnover in Patients on Hemodialysis. (2016) (62)
- The link between bone and coronary calcifications in CKD-5 patients on haemodialysis. (2011) (60)
- A new bisphosphonate, BM 21.0955, prevents bone loss associated with cessation of ovarian function in experimental dogs (1993) (57)
- 1,25-Dihydroxyvitamin D maintains bone cell activity, and parathyroid hormone modulates bone cell number in dogs. (1986) (55)
- Prevention of p.o. clotting of av. cimino fistulae with Acetylsalicyl acid results of a prospective double blind study (1974) (54)
- 22-oxacalcitriol suppresses secondary hyperparathyroidism without inducing low bone turnover in dogs with renal failure. (1999) (54)
- A new semiautomatic method for quantitative static and dynamic bone histology (1982) (54)
- Management of hyperphosphataemia of chronic kidney disease: lessons from the past and future directions. (2002) (53)
- Bone disease after renal transplantation (2010) (52)
- The activin receptor is stimulated in the skeleton, vasculature, heart, and kidney during chronic kidney disease. (2018) (50)
- 24R,25-Dihydroxyvitamin D3 and 1 alpha,25-dihydroxyvitamin D3 are both indispensable for calcium and phosphorus homeostasis. (1980) (50)
- Characterization of vitamin D receptor immunoreactivity in human bone cells. (2000) (49)
- 1,25-dihydroxyvitamin D3 corrects bone loss but suppresses bone remodeling in ovariohysterectomized beagle dogs. (1988) (46)
- Skeletal X-ray findings and bone histology in patients on hemodialysis. (1978) (45)
- Ligand trap of the activin receptor type IIA inhibits osteoclast stimulation of bone remodeling in diabetic mice with chronic kidney disease. (2017) (45)
- Intact PTH combined with the PTH ratio for diagnosis of bone turnover in dialysis patients: a diagnostic test study. (2010) (44)
- Effects of treatment of renal osteodystrophy on bone histology. (2008) (44)
- A program package for quantitative analysis of histologic structure and remodeling dynamics of bone. (1981) (43)
- The new kidney disease: improving global outcomes (KDIGO) guidelines - expert clinical focus on bone and vascular calcification. (2010) (43)
- Loss of bone resulting from accumulation of aluminum in bone of patients undergoing dialysis. (1986) (43)
- Relationship between bone histology and markers of bone and mineral metabolism in African-American hemodialysis patients. (2009) (42)
- Comparison of different bone-biopsy techniques for qualitative and quantitative diagnosis of metabolic bone diseases. (1983) (41)
- Low-energy fractures without low T-scores characteristic of osteoporosis: a possible bone matrix disorder. (2013) (37)
- Short-term administration of the bisphosphonate ibandronate increases bone volume and prevents hyperparathyroid bone changes in mild experimental renal failure. (2000) (37)
- Calcitriol, parathyroid hormone, and accumulation of aluminum in bone in dogs with renal failure. (1987) (35)
- Metabolic bone disease in patients on maintenance hemodialysis. (1974) (35)
- Secondary hyperparathyroidism and vitamin D receptor binding to vitamin D response elements in rats with incipient renal failure. (1997) (35)
- Aluminum-related bone disease. (1988) (34)
- Expression of DGCR8‐Dependent MicroRNAs Is Indispensable for Osteoclastic Development and Bone‐Resorbing Activity (2014) (30)
- Utilization of bone histomorphometry in renal osteodystrophy: demonstration of a new approach using data from a prospective study of lanthanum carbonate. (2005) (29)
- FGF-23 serum levels and bone histomorphometric results in adult patients with chronic kidney disease on dialysis (2014) (29)
- The five most commonly used intact parathyroid hormone assays are useful for screening but not for diagnosing bone turnover abnormalities in CKD-5 patients. (2009) (29)
- Effects of Sucroferric Oxyhydroxide Compared to Lanthanum Carbonate and Sevelamer Carbonate on Phosphate Homeostasis and Vascular Calcifications in a Rat Model of Chronic Kidney Failure (2015) (27)
- Calcitonin prevents bone loss but decreases osteoblastic activity in ovariohysterectomized beagle dogs (1996) (26)
- Effects of 1,25(OH)2D3 administration on bone in patients with renal failure. (1990) (26)
- Oncogenic Osteomalacia Associated with Metastatic Prostate Carcinoma: Case Report and Review of the Literature (1993) (26)
- SIRT6 deficiency culminates in low-turnover osteopenia. (2015) (26)
- Early therapy of renal bone disease with calcitriol: a prospective double-blind study. (1989) (26)
- Femoral bone mineral density reflects histologically determined cortical bone volume in hemodialysis patients (2010) (25)
- Isolation and complete amino acid sequence of osteocalcin from canine bone (1993) (25)
- Bone alkaline phosphatase isoforms in hemodialysis patients with low versus non-low bone turnover: a diagnostic test study. (2015) (25)
- Calcitriol in prolonged hypocalcemia due to the tumor lysis syndrome. (1989) (24)
- Bone biopsy in patients with osteoporosis (2007) (22)
- Interventional Nephrology and Dialysis: Bone Biopsy: Indications, Techniques, and Complications (2003) (22)
- Bone biopsy: indications, techniques, and complications. (2003) (22)
- Serum bone markers in ROD patients across the spectrum of decreases in GFR: Activin A increases before all other markers (2019) (22)
- Only minor differences in renal osteodystrophy features between wild-type and sclerostin knockout mice with chronic kidney disease. (2016) (21)
- Changes in total parathyroid hormone (PTH), PTH-(1-84) and large C-PTH fragments in different stages of chronic kidney disease. (2006) (20)
- The Effect of Class A Scavenger Receptor Deficiency in Bone* (2007) (20)
- Vitamin D receptor interactions with positive and negative DNA response elements: an interference footprint comparison (2000) (20)
- Role of cytokines in renal osteodystrophy (1997) (20)
- Opposite effects of calcitriol and paricalcitol on the parathyroid hormone-(1-84)/large carboxy-terminal-parathyroid hormone fragments ratio in patients with stage 5 chronic kidney disease. (2007) (19)
- Aluminum intoxication of bone in renal failure--fact or fiction? (1986) (19)
- Five-year postoperative results of cemented femoral arthroplasty in patients with systemic bone disease. (1990) (19)
- Transactivation of the parathyroid hormone promoter by specificity proteins and the nuclear factor Y complex. (2005) (19)
- Suppression of the Human Parathyroid Hormone Promoter by Vitamin D Involves Displacement of NF-Y Binding to the Vitamin D Response Element* (2004) (18)
- Moderately high consumption of ethanol suppresses bone resorption in ovariectomized but not in sexually intact adult female rats. (1997) (18)
- Sp3/Sp1 in the parathyroid gland: identification of an Sp1 deoxyribonucleic acid element in the parathyroid hormone promoter. (2003) (17)
- Retinoic acid receptor gamma 2 interactions with vitamin D response elements (2010) (16)
- Oxalosis in bone causing a radiographical mimicry of renal osteodystrophy. (1987) (16)
- Stiffness and strength of bone in osteoporotic patients treated with varying durations of oral bisphosphonates (2016) (15)
- Effects of parathyroidectomy on circulating levels of 1 alpha,25-dihydroxyvitamin D and bone Gla protein in dialyzed patients. (1986) (15)
- Selectivity of a C-terminal peptide antiserum for different DNA-binding states of the vitamin D receptor. (1998) (15)
- Peritonitis due to Exophiala jeanselmei in a patient undergoing continuous ambulatory peritoneal dialysis. (1993) (15)
- Sotatercept Safety and Effects on Hemoglobin, Bone, and Vascular Calcification (2019) (14)
- [Use and indication of vitamin D and vitamin D analogues in patients with renal bone disease]. (2002) (14)
- A Survey Study of Self-Rated Patients’ Knowledge About AKI in a Post-Discharge AKI Clinic (2019) (14)
- Diagnosis of low bone mass in CKD-5D patients (2015) (14)
- Chapter 8 – Bone Biopsies: A Modern Approach (1998) (13)
- Isolation of genomic DNA sequences that bind vitamin D receptor complexes. (2001) (12)
- Aluminum: toxin or innocent bystander in renal osteodystrophy. (1985) (12)
- Disturbed Synthesis of Type II Collagen Interferes with Rate of Bone Formation and Growth and Increases Bone Resorption in Transgenic Mice (2008) (12)
- Renal bone disease--an ongoing challenge to the nephrologist. (1995) (12)
- Coronary artery calcification in CKD-5D patients is tied to adverse cardiac function and increased mortality (2016) (12)
- [Some topical problems of subtotal parathyroidectomy in patients on haemodialysis]. (1973) (12)
- Renal osteodystrophy. (1989) (11)
- Role of calcitriol in the management of osteoporosis. (1990) (11)
- Values of noninvasive techniques in predicting bone histology. (1988) (11)
- Long‐term outcomes and management considerations after parathyroidectomy in the dialysis patient (2019) (10)
- Skeletal lesions and calcium metabolism in early renal failure. (1975) (10)
- The possible use of bisphosphonates in the treatment of renal osteodystrophy. (1992) (10)
- Dialysis: current status, contemporary limitations and future challenges. (1995) (10)
- Higher mineralized bone volume is associated with a lower plain X-Ray vascular calcification score in hemodialysis patients (2017) (10)
- Long-term administration of vitamin D steroles in incipient and advanced renal failure: effect on bone histology. (1978) (10)
- Importance of bone turnover for therapeutic decisions in patients with CKD-MBD. (2021) (9)
- Pth 1-84, Pth fragments and bone turnover. (2003) (9)
- Regulation of 25‐hydroxyvitamin D3 metabolism in cultures of osteoblastic cells (1990) (9)
- Changes of bone histology during maintenance hemodialysis at various levels of dialyzate Ca concentration. (1976) (9)
- Long-term effect of oral calcitriol pulse therapy on bone in hemodialysis patients. (1993) (9)
- Alkaline phosphatase bone isoenzyme activity in serum in various degrees of micromorphometrically assessed renal osteopathy. (1980) (9)
- Endogenous calcitonin does not protect against hyperparathyroid bone disease in renal failure. (1986) (8)
- 1,25(OH) 2 D 3 administration in moderate renal failure (1989) (8)
- 14 Renal Bone Disease (1986) (8)
- Biomarkers of Bone Turnover Identify Subsets of Chronic Kidney Disease Patients at Higher Risk for Fracture. (2020) (8)
- Development and characterization of a polyclonal antiserum‐based radioimmunoassay for dog osteocalcin (1993) (7)
- Contrasting mammalian parathyroid hormone (PTH) promoters: nuclear factor-Y binds to a deoxyribonucleic acid element unique to the human PTH promoter and acts as a transcriptional enhancer. (2004) (7)
- Low Turnover Renal Osteodystrophy With Abnormal Bone Quality and Vascular Calcification in Patients With Mild-to-Moderate CKD (2022) (7)
- Young’s modulus and hardness of human trabecular bone with bisphosphonate treatment durations up to 20 years (2018) (6)
- Effect of 1,25-vitamin D and parathyroidectomy on the uptake of aluminum in bone of rats with renal insufficiency. (1988) (6)
- Treatment of aluminum toxicity in infantile uremia with deferoxamine. (1986) (6)
- Serum phosphorus adds to value of serum parathyroid hormone for assessment of bone turnover in renal osteodystrophy. (2016) (6)
- Uremic bone disease: current knowledge, controversial issues, and new horizons. (1991) (6)
- Absence of adynamic bone disease in African-Americans with CKD stage 5 after 3 years of vitamin D therapy guided by iPTH and the PTH-(1-84)/N-terminally truncated PTH fragments ratio. (2009) (6)
- Recurrent fractures, hypophosphatemia, and renal insufficiency in an elderly woman. (1984) (5)
- Molecular bone morphometry (2000) (5)
- Bone Quality and Fractures in Women With Osteoporosis Treated With Bisphosphonates for 1 to 14 Years (2021) (5)
- Preventive effects of the new bisphosphonate, BM21.0955, on the bone loss occurring after cessation of ovarian function in experimental dogs (1992) (5)
- More on aluminum toxic effects in children with uremia. (1990) (4)
- Histomorphometric analysis of tricalcium phosphate ceramic implanted into turkeys. (1992) (4)
- Update on vitamin D and its newer analogues (2003) (4)
- Comparison between different methods of measurement of bone resorption (1992) (3)
- Bicarbonate dialysis--so what? (1985) (3)
- The Role of Alterations in Alpha-Klotho and FGF-23 in Kidney Transplantation and Kidney Donation (2022) (3)
- Renal Osteodystrophy Is a Multifaceted Disease with No Uniform Therapy (1993) (3)
- PROSPECTS FOR THE MODELLING OF VITAMIN D ACTIVITY IN MAN (1988) (2)
- 12 Bone Disease in Primary Hyperparathyroidism (1986) (2)
- Use and indication of vitamin D and vitamin D analogues in patients with renal bone disease. (2002) (2)
- Prevalence of low bone formation in untreated patients with osteoporosis (2022) (2)
- Hypercalcemia and human nature. (2001) (2)
- Parathyroid Hormone Type 1 Receptor and Human Osteoclasts (2002) (2)
- Contrasting mammalian PTH promoters: identification of transcription factors controlling PTH gene expression. (2005) (2)
- 7 Technique of Mineralized Bone Histology (1986) (2)
- Disturbed Terminal Mineralization of Bone in Idiopathic Hypercalciuria (1981) (1)
- 8 Evaluation of Mineralized Bone Histology (1986) (1)
- Structural and cellular characteristics of proximal femoral bone in patients for total HIP replacement (1992) (1)
- REGULATION OF PHOSPHATE IN HEALTH AND DISEASE * — (2007) (1)
- Differences in Bone Quality between High versus Low Turnover Renal Osteodystrophy (2012) (1)
- Intestinal calcium absorption and whole-body calcium retention in various stages of renal insufficiency (1975) (1)
- 6 Bone Biopsy (1986) (1)
- Bone mineral density compares and contrasts with the biomechanical measurements of canine bone. (1996) (1)
- Bone densitometry of osteopetrosis in an adolescent girl. (1990) (1)
- 22-oxacalcitriol suppresses parathyroid hormone secretion and preserves bone turnover in dogs with renal failure. (1996) (1)
- PTH regulation of the human cytomegalovirus immediate-early gene promoter. (2008) (1)
- 4 Bone Modeling and Remodeling (1986) (1)
- 133: Lanthanum Carbonate vs Standard Phosphate Binder Therapy: Evolution of Renal Osteodystrophy Over 1 and 2 Years of Treatment (2007) (1)
- [Thiosemicarbazone therapy of tuberculosis]. (1952) (1)
- 15 Paget’s Disease of Bone (1986) (0)
- 18 Correlations between Histopathology of Bone and Serum Biochemistry (1986) (0)
- 5 Bone and Mineral Homeostasis (1986) (0)
- BONE COMPLICATIONS AND CALCIFICATION OF SOFT TISSUES IN CHRONIC KIDNEY DISEASE (2007) (0)
- Transcription factor HNF4α2 promotes osteogenesis and prevents bone abnormalities in mice with renal osteodystrophy. (2023) (0)
- Kongresse – Reunions – Meetings (1954) (0)
- Long-term effects of “oral 1,25(OH)2d3 pulse therapy” on bone in hemodialyzed patients (1992) (0)
- Bone alkaline phosphatase isoforms in CKD patients on hemodialysis with low and high bone turnover (2014) (0)
- [Skeletal histology in uremic osteodystrophy following increase of dialysate calcium concentration to 3,75 mval-1 (preliminary report)]. (1973) (0)
- Title Page / Dedication / Contents / Foreword / Preface / Introduction (1986) (0)
- Protective effect of 1 25 di hydroxy vitamin d against bone loss in oophorectomized rats (1982) (0)
- 2 Bone Cells (1986) (0)
- Prevention of bone disease in renal failure (1991) (0)
- Tempora mutantur et nos mutamur in illis - Times are changing, and so are we. (2009) (0)
- TREATMENT OPTIONS IN THE MANAGEMENT OF PHOSPHATE RETENTION (2007) (0)
- [New aspects in the asylum problem]. (1949) (0)
- The Sulfonamide Therapy of extrapulmonary Tuberculosis. (1947) (0)
- Treatment of bone loss in CKD5D: Better survival in patients with non-high bone turnover. (2022) (0)
- Experiences to Date of the Treatment of Tuberculosis with Thiosemicarbazone. (1949) (0)
- Rabbit study of novel delivery vehicles for rhBMP (1996) (0)
- Bone Quality and Total Joint Arthroplasty (2013) (0)
- [Exudate resorption property of thiosemicarbazone Tb 698]. (1950) (0)
- 17 Bone Abnormalities Resulting from Miscellaneous Causes (1986) (0)
- Interrelations between calcium kinetic parameters and biochemical and histomorphometric findings (1992) (0)
- [Monaldi's cavern drainage combined with specific antituberculosis therapy]. (1950) (0)
- [Combined intracavernous conteben (TB I) therapy]. (1951) (0)
- Combined Cavity Therapy with TB1. (1951) (0)
- 1,25R,26 (OH)3-22 ENE D3, A NOVEL THERAPEUTIC AGENT FOR REVERSAL OF BONE LOSS ASSOCIATED WITH CESSATION OF OVARIAN FUNCTION (1991) (0)
- Bone disease in renal failure. Introduction. (1991) (0)
- [The value of extrapleural pneumothorax within the framework of the current treatment of tuberculosis]. (1961) (0)
- The need for healing places and differential diagnosis of childhood pulmonary tuberculosis. (1948) (0)
- Suppression of PTH secretion without concomitant decrease in bone turnover in renal failure (1996) (0)
- 8 Animal Models tor Osteoporosis (1994) (0)
- Erosion depth is paralleled by expression of mRNA for interleukin-6 receptor in osteoclasts (1996) (0)
- FIELD OF THE INVENTION (2017) (0)
- Parathyroid hormone and 1.25 vitamin D3 exert opposite effects on bone. (1986) (0)
- 16 Bone Abnormalities Associated with Systemic Disorders (1986) (0)
- 1595 MILK FORMULA CAUSES ALUMINUM (AL) TOXICITY IN UREMIC INFANTS (1985) (0)
- 3 Lamellar and Woven Bone (1986) (0)
- 13 Bone Disease Associated with Malignancies (1986) (0)
- FP406THE ROLE OF ACTIVIN SIGNALING IN THE PATHOGENESIS OF RENAL OSTEODYSTROPHY OF CKD-MBD (2015) (0)
- Trabecular bone microcrack accumulation in patients treated with bisphosphonates for durations up to 16 years (2022) (0)
- [Preliminary clinical results of the therapy of tuberculosis with isonicotinic acid hydrazide]. (1952) (0)
- References / Subject Index (1986) (0)
- Bone disease - 2 (2009) (0)
- [Pneumolysis after drainage]. (1953) (0)
- Alkaline phosphatase bone isoform B1x: a marker of impaired osteoblastic function in patients with renal osteodystrophy (2014) (0)
- FGF-23 and sclerostin in serum and bone of CKD patients. (2023) (0)
- [Intestinal calcium absorption in the early stage of renal insufficiency and the effect of 5,6-trans-25-OHCC]. (1977) (0)
- [Serum gastrin level and gastric juice secretion in chronic hemodialysis patients and their modifications through changes in ionized serum calcium achieved by dialysis or parathyroidectomy]. (1974) (0)
- [Clinical evaluation of tubersan]. (1951) (0)
- Calcium kinetics studies in patients with renal osteodystrophy (1992) (0)
- [Extrapleural pneumolysis as the final step after the drainage of cavities]. (1954) (0)
- Erratum: Renal osteodystrophy in the first decade of the new millennium: analysis of 630 bone biopsies in black and white patients (2011) (0)
- [Conservative and surgical therapy of Goodpasture's syndrome]. (1973) (0)
- Author response for "Bone Quality and Fractures in Women with Osteoporosis Treated with Bisphosphonates for One to Fourteen Years" (2021) (0)
- Histologic Abnormalities of Bone before and after Kidney Transplantation (2005) (0)
- Nephrology at the verge of the century, Ulm, Germany, November 11-12, 1994 (1995) (0)
- [Hypergastrinemia, hypercalcemia and stomach secretion (studies in chronic dialysis patients with secondary hyperparathyroidism before and after parathyroidectomy)]. (1974) (0)
- 1 Functional and Structural Organization of Bone (1986) (0)
- [Serum gastrin level and gastric juice secretion in chronic hemodialysis patients and its effect on them by changing ionized serum calcium]. (1974) (0)
- [Extrapleural pneumothorax as closure after cavitary drainage]. (1954) (0)
- Introduction to Calcium Symposium (1973) (0)
- [Experimental studies on parathyroid hormone resistance of the skeleton in kidney insufficiency]. (1977) (0)
- Preliminary Clinical Experiences of the Treatment of Tuberculosis with Isonicotinic Acid Hydrazide, INH. (1952) (0)
- Correction of bone loss with estrogen deficiency by 24-EPI-1α,25-dihydroxyvitamin D2 (1996) (0)
- 311: Bone Disease in Long Term Post Renal Transplant Patients: Single Center Experience (2010) (0)
- 10 Defective Mineralization and Osteomalacia (1986) (0)
- Animal Models for Osteoporosis (1994) (0)
- [Secondary hyperparathyroidism in renal insufficiency. Prevention and therapy]. (1976) (0)
- Response to “Low Turnover Bone Disease in Early CKD Stages” (2022) (0)
- In memoriam: Reinhold Kluthe (2007) (0)
- SP645QUANTITATIVE COMPUTED TOMOGRAPHY RESULTS FOR BONE MASS AND ABDOMINAL AORTIC VASCULAR CALCIFICATION IN HEMODIALYSIS SUBJECTS TREATED WITH ESCALATING DOSE LEVELS OF SOTATERCEPT: INTERIM ANALYSIS OF ACE-011-REN-001 (2015) (0)
- [The value of tomography for the recognition of spinal tuberculosis]. (1953) (0)
- Bone — Normal Structure and Physiology (2002) (0)
- [The renal osteodystrophy of bilateral nephrectomised patients with preoperative normal skeletal histology during chronic hemodialysis (author's transl)]. (1974) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Hartmut H. Malluche?
Hartmut H. Malluche is affiliated with the following schools:
